摘要
目的探讨分析磷酸肌酸钠与神经节苷脂早期治疗重度窒息新生儿的临床疗效。方法选取我院重度窒息新生儿60例,随机分为两组,均给予常规治疗,观察组加用磷酸肌酸钠联合神经节苷脂治疗,分析两组临床疗效。结果与对照组患儿相比,观察组患儿临床体征恢复时间较短,并发症发生率较低,差异有统计学意义(P<0.05)。结论给予重度窒息新生儿磷酸肌酸钠联合神经节苷脂早期治疗,能有效减少并发症的发生,提高新生儿的治愈率,具有较好的临床疗效。
Objective To investigate the clinical efficacy analysis phosphate sodium and ganglioside early treatment of severe neonatal asphyxia. Methods Selected 60 cases of severe asphyxia newborns in our hospital, which were randomly divided into two groups given conventional treatment, observation group were treated with phosphate sodium therapy of ganglioside. Analysis of clinical efficacy. Results Compared with the control group of children, clinical signs observed group of children shorter recovery time, low complication rate, and the difference was statistically significant（P〈0.05）. Conclusion The administration of severe neonatal asphyxia muscle sodium phosphate combined with ganglioside early treatment, can effectively reduce the incidence of complications, improve the cure rate of newborns with better clinical efficacy.
出处
《中国继续医学教育》
2016年第6期154-155,共2页
China Continuing Medical Education
